Jane E. Mackie
Impact in
- Oncology top 1%
- Drug Transport and Resistance Mechanisms
- Cancer Cells and Metastasis
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Pharmacogenetics and Drug Metabolism 3
- Drug-Induced Hepatotoxicity and Protection 2
-
- Porphyrin Metabolism and Disorders 8
- Co-authors
- Susan P.C. Cole (2 shared papers)Kurt C. Almquist (2 shared papers)Ebba U. Kurz (1 shared paper)James H. Gerlach (1 shared paper)R G Deeley (1 shared paper)Caroline E. Grant (1 shared paper)Alistair J. Stewart (1 shared paper)Alessandra M.V. Duncan (1 shared paper)
- Journals
- Biochemical Pharmacology (3 papers)Canadian Journal of Physiology and Pharmacology (3 papers)Clinical Biochemistry (1 paper)Experimental Biology and Medicine (1 paper)The FASEB Journal (1 paper)
- Partner nations
- CanadaUnited States
In The Last Decade
Jane E. Mackie
13 papers receiving 2.8k citations
Jane E. Mackie's Hit Papers
Peers
Comparison fields: 5 of 78
- Oncology 2.2k
- Pharmacology 119
- Molecular Biology 405
- Biomaterials 72
- Hematology 62
Countries citing papers authored by Jane E. Mackie
This map shows the geographic impact of Jane E. Mackie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane E. Mackie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane E. Mackie more than expected).
Fields of papers citing papers by Jane E. Mackie
This network shows the impact of papers produced by Jane E. Mackie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane E. Mackie. The network helps show where Jane E. Mackie may publish in the future.
Co-authors
The 23 scholars most cited alongside Jane E. Mackie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell Line Hit paper breakdown → | 1992 | 2685 |
| 2 | Characterization of the M(r) 190,000 multidrug resistance protein (MRP) in drug-selected and transfected human tumor cell. | 1995 | 137 |
| 3 | 1988 | 71 | |
| 4 | 1992 | 18 | |
| 5 | 1988 | 12 | |
| 6 | 1961 | 10 | |
| 7 | 1989 | 7 | |
| 8 | 1989 | 7 | |
| 9 | 1991 | 7 | |
| 10 | 1990 | 5 | |
| 11 | 1990 | 4 | |
| 12 | 1989 | 3 | |
| 13 | 1991 | 2 |
About Jane E. Mackie
Jane E. Mackie is a scholar working on Pharmacology, Molecular Biology, Oncology, Hepatology and Inorganic Chemistry, having authored 13 papers that have together received 3k indexed citations. Recurring topics across this work include Porphyrin Metabolism and Disorders (8 papers), Pharmacogenetics and Drug Metabolism (3 papers), Drug Transport and Resistance Mechanisms (2 papers), Drug-Induced Hepatotoxicity and Protection (2 papers), Liver Disease and Transplantation (1 paper), Alcohol Consumption and Health Effects (1 paper), Liver Disease Diagnosis and Treatment (1 paper) and Metal-Catalyzed Oxygenation Mechanisms (1 paper). The work is most often cited by research in Oncology (2.2k citations), Pharmacology (119 citations), Molecular Biology (405 citations), Biomaterials (72 citations) and Hematology (62 citations). Jane E. Mackie has collaborated with scholars based in Canada and United States. Frequent co-authors include Susan P.C. Cole, Kurt C. Almquist, Ebba U. Kurz, James H. Gerlach, R G Deeley, Caroline E. Grant, Alistair J. Stewart, Alessandra M.V. Duncan, Gerald Samuel Marks and Roger G. Deeley. Their work appears in journals such as Biochemical Pharmacology, Canadian Journal of Physiology and Pharmacology, Clinical Biochemistry, Experimental Biology and Medicine and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.